Should Voriconazole be the Primary Therapy for Chronic Invasive Sinus Aspergillosis (CISA)?

E-ISSN： 0975-6965|4|1|21-26

ISSN： 0974-4630

Source： An International Journal Clinical Rhinology, Vol.4, Iss.1, 2011-01, pp. : 21-26

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Should Voriconazole be the Primary Therapy for Chronic Invasive Sinus Aspergillosis (CISA)?

An International Journal Clinical Rhinology, Vol. 4, Iss. 1, 2011-01 ,pp. : 27-37

Jaypee Infomedia

Access to resources Recommend Favorite

Voriconazole: In the Treatment of Invasive Aspergillosis

By Muijsers R.B.R. Goa K.L. Scott L.J.

Drugs, Vol. 62, Iss. 18, 2002-01 ,pp. : 2655-2664

Adis International

Access to resources Recommend Favorite

Chronic Invasive Sinus Aspergillosis in Immunocompetent Hosts: A Geographic Comparison

By Webb Brandon Vikram Holenarasipur

Mycopathologia, Vol. 170, Iss. 6, 2010-12 ,pp. : 403-410

Springer Publishing Company

Access to resources Recommend Favorite

Breakthrough invasive pulmonary aspergillosis despite empirical voriconazole therapy for febrile neutropenia: Case report and review of the literature

By Meyer Marianne Waldvogel Sophie Chalandon Yves Bongiovanni Massimo Pache Jean-Claude Van Delden Christian

Scandinavian Journal of Infectious Diseases, Vol. 39, Iss. 8, 2007-01 ,pp. : 731-733

Informa Healthcare

Access to resources Recommend Favorite

Voriconazole best value for invasive aspergillosis in Spain

Inpharma, Vol. 1, Iss. 1582-1583, 2007-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite